| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1d47ea4a98d4d599e0ff810991424307
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a61c11d10dd703b85946a6f210e064f2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-782 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D275-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-49 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D275-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q3-02 |
| filingDate |
1991-03-07^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1997-06-11^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d595741801123937c07ffc664018194f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d99093ed23a3af9e2eddb0c8a3309bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5cdd9d1cc25590b1652adc23dd0120d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b7e1201fd3bd3c0b154942944647b94 |
| publicationDate |
1997-06-11^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0446047-B1 |
| titleOfInvention |
Benzisothiazolinone-1-dioxide derivatives as elastase inhibitors |
| abstract |
The invention relates to pharmaceutical and cosmetic compositions comprising at least one benzisothiazolinone-1-dioxide derivative with the formula: <CHEM> where R<1> can be hydrogen, and R<2> can be certain generally hydrophobic C8-C20 aliphatic groups or the group: <CHEM> where R<5> is aliphatic or else R<2> is a saturated or unsaturated C2-C6 group ending in an aromatic nucleus. These compositions can be used to inhibit elastases such as human leucocytic elastase. They may be applied topically as a cosmetic. Many of the benzisothiazolinone-1-dioxide derivative specified as active ingredient in such compositions are novel compounds. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-1906181-B |
| priorityDate |
1990-03-08^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |